US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 61.500
  • -1.950-3.07%
Close Dec 12 16:00 ET
  • 61.500
  • 0.0000.00%
Post 16:20 ET
3.61BMarket Cap-52.56P/E (TTM)

Janux Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Janux Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.211M--
--2024/Q4-- / 490.000K--
--2024/Q3439.000K / 1.645M--
--2024/Q28.897M / 863.120K--
--2024/Q11.252M / 1.018M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.211M--
--2024/Q4-- / 490.000K--
--2024/Q3439.000K / 1.645M--
--2024/Q28.897M / 863.120K--
--2024/Q11.252M / 1.018M--

Unlock Free Earnings Estimates

Janux Therapeutics Earnings Reports

  • Janux Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:29 ET

  • Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 6 16:15 ET

  • Janux Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 22:24 ET

  • Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 7 16:28 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      9.09%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data